Resolvin D1 reduces the immunoinflammatory response of the rat eye following uveitis

Mediators of Inflammation

Volumn 2012, Issue , 2012, Pages

  Settimio, Rossi ^a   Clara, Di Filippo ^a   Franca, Ferraraccio ^a   Francesca, Simonelli ^a   Michele, D'Amico ^a  

^a SECOND UNIVERSITY OF NAPLES   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AGENTS ACTING ON THE EYE; CD11B ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; INTERLEUKIN 8; MYELOPEROXIDASE; RANTES; RESOLVIN D1; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; CHEMOKINE; CYTOKINE; DOCOSAHEXAENOIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; AQUEOUS HUMOR; ARTICLE; ENZYME ACTIVITY; IMMUNE RESPONSE; MALE; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; RAT; T LYMPHOCYTE; UVEITIS; ANIMAL; IMMUNOLOGY; SPRAGUE DAWLEY RAT;

RATTUS;

ANIMALS; CHEMOKINES; CYTOKINES; DOCOSAHEXAENOIC ACIDS; MALE; RATS; RATS, SPRAGUE-DAWLEY; T-LYMPHOCYTES; UVEITIS;

MLCS; MLOWN;

EID: 84872135600     PISSN: 09629351     EISSN: 14661861     Source Type: Journal    
DOI: 10.1155/2012/318621     Document Type: Article

References (43)

1. Rossi S., D'Amico M., Capuano A., Romano M., Petronella P., Di Filippo C., Hyperglycemia in streptozotocin-induced diabetes leads to persistent inflammation and tissue damage following uveitis due to reduced levels of ciliary body heme oxygenase-1. Mediators of Inflammation 2006 2006 4 2-s2.0-33746620925 10.1155/MI/2006/60285 60285 (Pubitemid 44147689)
2. Serhan C. N., Resolution phase of inflammation: novel endogenous anti-inflammatory and proresolving lipid mediators and pathways. Annual Review of Immunology 2007 25 101 137 2-s2.0-34247847681 10.1146/annurev.immunol.25. 022106.141647 (Pubitemid 46697904)
3. Fredman G., Serhan C. N., Specialized proresolving mediator targets for RvE1 and RvD1 in peripheral blood and mechanisms of resolution. Biochemical Journal 2011 437 2 185 197 2-s2.0-79959720828 10.1042/BJ20110327
4. Sun Y. P., Oh S. F., Uddin J., Yang R., Gotlinger K., Campbell E., Colgan S. P., Petasis N. A., Serhan C. N., Resolvin D1 and its aspirin-triggered 17R epimer: stereochemical assignments, anti-inflammatory properties, and enzymatic inactivation. Journal of Biological Chemistry 2007 282 13 9323 9334 2-s2.0-34248233132 10.1074/jbc.M609212200 (Pubitemid 47104612)
5. Schwab J. M., Chiang N., Arita M., Serhan C. N., Resolvin E1 and protectin D1 activate inflammation-resolution programmes. Nature 2007 447 7146 869 874 2-s2.0-34250357688 10.1038/nature05877 (Pubitemid 46920139)
6. Ariel A., Fredman G., Sun Y. P., Kantarci A., Van Dyke T. E., Luster A. D., Serhan C. N., Apoptotic neutrophils and T cells sequester chemokines during immune response resolution through modulation of CCR5 expression. Nature Immunology 2006 7 11 1209 1216 2-s2.0-33750112087 10.1038/ni1392 (Pubitemid 44594317)
7. Campbell E. L., Louis N. A., Tomassetti S. E., Canny G. O., Arita M., Serhan C. N., Colgan S. P., Resolvin E1 promotes mucosal surface clearance of neutrophils: a new paradigm for inflammatory resolution. FASEB Journal 2007 21 12 3162 3170 2-s2.0-35248868413 10.1096/fj.07-8473com
8. Serhan C. N., Chiang N., Van Dyke T. E., Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediators. Nature Reviews Immunology 2008 8 5 349 361 2-s2.0-42649089790 10.1038/nri2294 (Pubitemid 351595216)
9. Ariel A., Serhan C. N., Resolvins and protectins in the termination program of acute inflammation. Trends in Immunology 2007 28 4 176 183 2-s2.0-33947500462 10.1016/j.it.2007.02.007 (Pubitemid 46467520)
10. Xu Z. Z., Zhang L., Liu T., Park J. Y., Berta T., Yang R., Serhan C. N., Ji R. R., Resolvins RvE1 and RvD1 attenuate inflammatory pain via central and peripheral actions. Nature Medicine 2010 16 5 592 597 2-s2.0-77952237425 10.1038/nm.2123
11. Behar-Cohen F. F., Savoldelli M., Parel J. M., Goureau O., Thillaye-Goldenberg B., Courtois Y., Pouliquen Y., De Kozak Y., Reduction of corneal edema in endotoxin-induced uveitis after application of L-NAME as nitric oxide synthase inhibitor in rats by iontophoresis. Investigative Ophthalmology and Visual Science 1998 39 6 897 904 2-s2.0-0031965816 (Pubitemid 28196675)
12. Kernacki K. A., Berk R. S., Characterization of arachidonic acid metabolism and the polymorphonuclear leukocyte response in mice infected intracorneally with Pseudomonas aeruginosa. Investigative Ophthalmology and Visual Science 1995 36 1 16 23 2-s2.0-0028814986
13. Girgis D. O., Sloop G. D., Reed J. M., O'Callaghan R. J., A new topical model of Staphylococcus corneal infection in the mouse. Investigative Ophthalmology and Visual Science 2003 44 4 1591 1597 2-s2.0-0037377987 10.1167/iovs.02-0656 (Pubitemid 36378586)
14. Yang X., Jin H., Liu K., Gu Q., Xu X., A novel peptide derived from human pancreatitis-associated protein inhibits inflammation in vivo and in vitro and blocks NF-kappa B signaling pathway. PLoS ONE 2011 6 12 e29155
15. Serhan C. N., Petasis N. A., Resolvins and protectins in inflammation resolution. Chemical Reviews 2011 111 10 5922 5943
16. Perretti M., D'Acquisto F., Annexin A1 and glucocorticoids as effectors of the resolution of inflammation. Nature Reviews Immunology 2009 9 1 62 70 2-s2.0-58149094363 10.1038/nri2470
17. Rivière S., Challet L., Fluegge D., Spehr M., Rodriguez I., Formyl peptide receptor-like proteins are a novel family of vomeronasal chemosensors. Nature 2009 459 7246 574 577 2-s2.0-66449113577 10.1038/nature08029
18. Krishnamoorthy S., Recchiuti A., Chiang N., Yacoubian S., Lee C. H., Yang R., Petasis N. A., Serhan C. N., Resolvin D1 binds human phagocytes with evidence for proresolving receptors. Proceedings of the National Academy of Sciences of the United States of America 2010 107 4 1660 1665 2-s2.0-76549124239 10.1073/pnas.0907342107
19. Tian H., Lu Y., Sherwood A. M., Hongqian D., Hong S., Resolvins el and dl in choroid-retinal endothelial cells and leukocytes: biosynthesis and mechanisms of anti-inflammatory actions. Investigative Ophthalmology and Visual Science 2009 50 8 3613 3620 2-s2.0-68349113741 10.1167/iovs.08-3146
20. Ajuebor M. N., Swain M. G., Perretti M., Chemokines as novel therapeutic targets in inflammatory diseases. Biochemical Pharmacology 2002 63 7 1191 1196 2-s2.0-0036535980 10.1016/S0006-2952(02)00854-7 (Pubitemid 34311988)
21. Ajuebor M. N., Virág L., Flower R. J., Perretti M., Szabó C., Role of inducible nitric oxide synthase in the regulation of neutrophil migration in zymosan-induced inflammation. Immunology 1998 95 4 625 630 2-s2.0-0031742316 10.1046/j.1365-2567.1998.00644.x (Pubitemid 28559157)
22. Vicente A. M., Guillén M. I., Alcaraz M. J., Participation of heme oxygenase-1 in a model of acute inflammation. Experimental Biology and Medicine 2003 228 5 514 516 2-s2.0-0141457692 (Pubitemid 37203669)
23. Cuello C., Wakefield D., Di Girolamo N., Neutrophil accumulation correlates with type IV collagenase/gelatinase activity in endotoxin induced uveitis. British Journal of Ophthalmology 2002 86 3 290 295 2-s2.0-0036200596 10.1136/bjo.86.3.290 (Pubitemid 34206342)
24. Thorne S. A., Abbot S. E., Stevens C. R., Winyard P. G., Mills P. G., Blake D. R., Modified low density lipoprotein and cytokines mediate monocyte adhesion to smooth muscle cells. Atherosclerosis 1996 127 2 167 176 2-s2.0-0030596070 10.1016/S0021-9150(96)05948-5 (Pubitemid 27045830)
25. He J., Kakazu A. H., Bazan N. G., Bazan H. E. P., Aspirin-triggered lipoxin A4 (15-epi-LXA4) increases the endothelial viability of human corneas storage in Optisol-GS. Journal of Ocular Pharmacology and Therapeutics 2011 27 3 235 241 2-s2.0-79958825526 10.1089/jop.2010.0187
26. Odusanwo O., Chinthamani S., McCall A., Duffey M. E., Baker O. J., Resolvin D1 prevents TNF-á-mediated disruption of salivary epithelial formation. American Journal of Physiology 2012 302 9 C1331 C1345
27. Forrester J. V., Xu H., Lambe T., Cornall R., Immune privilege or privileged immunity? Mucosal Immunology 2008 1 5 372 381 2-s2.0-50149115789 10.1038/mi.2008.27
28. Forrester J. V., Privilege revisited: an evaluation of the eye's defence mechanisms. Eye 2009 23 4 756 766 2-s2.0-65349094002 10.1038/eye.2008.259
29. Willermain F., Rosenbaum J. T., Bodaghi B., Interplay between innate and adaptive immunity in the development of non-infectious uveitis. Progress in Retinal and Eye Research 2012 31 2 182 194
30. Kogiso M., Tanouchi Y., Mimura Y., Nagasawa H., Himeno K., Endotoxin-induced uveitis in mice. 1. Induction of uveitis and role of T lymphocytes. Japanese Journal of Ophthalmology 1992 36 3 281 290 2-s2.0-0026448882
31. McMenamin P. G., Crewe J., Endotoxin-induced uveitis: kinetics and phenotype of the inflammatory cell infiltrate and the response of the resident tissue macrophages and dendritic cells in the iris and ciliary body. Investigative Ophthalmology and Visual Science 1995 36 10 1949 1959 2-s2.0-0029120404
32. Avunduk A. M., Avunduk M. C., Oztekin E., Baltaci A. K., Characterization of T lymphocyte subtypes in endotoxin-induced uveitis and effect of pentoxifylline treatment. Current Eye Research 2002 24 2 92 98 2-s2.0-0035986467 10.1076/ceyr.24.2.92.8157 (Pubitemid 34775525)
33. Trinh L., Brignole-Baudouin F., Pauly A., Liang H., Houssier M., Baudouin C., Th1-and Th2-related chemokine and chemokine receptor expression on the ocular surface in endotoxin-induced uveitis. Molecular Vision 2008 14 2428 2434 2-s2.0-58049200684
34. Schall T. J., Jongstra J., Dyer B. J., Jorgensen J., Clayberger C., Davis M. M., Krensky A. M., A human T cell-specific molecule is a member of a new gene family. Journal of Immunology 1988 141 3 1018 1025 2-s2.0-0023687643
35. Krensky A. M., Biology of the Chemokine in Rantes (Molecular Biology Intelligence Unit) 1995 R. G. Landes Co
36. Song A., Chen Y. F., Thamatrakoln K., Storm T. A., Krensky A. M., RFLAT-1: a new zinc finger transcription factor that activates RANTES gene expression in T lymphocytes. Immunity 1999 10 1 93 103 2-s2.0-0033024375 10.1016/S1074-7613(00)80010-2 (Pubitemid 29077387)
37. Song A., Nikolcheva T., Krensky A. M., Transcriptional regulation of RANTES expression in T lymphocytes. Immunological Reviews 2000 177 236 245 2-s2.0-0033653644
38. Daugherty B. L., Siciliano S. J., DeMartino J. A., Malkowitz L., Sirotina A., Springer M. S., Cloning, expression, and characterization of the human eosinophil eotaxin receptor. Journal of Experimental Medicine 1996 183 5 2349 2354 2-s2.0-0029951387 10.1084/jem.183.5.2349 (Pubitemid 26158926)
39. Struyf S., Menten P., Lenaerts J. P., Diverging binding capacities of natural LD78beta isoforms of macrophage inflammatory protein-1alpha to the CC chemokine receptors 1, 3 and 5 affect their anti-HIV-1 activity and chemotactic potencies for neutrophils and eosinophils. European Journal of Immunology 2001 7 2170 2178 (Pubitemid 32640734)
40. Slimani H., Charnaux N., Mbemba E., Saffar L., Vassy R., Vita C., Gattegno L., Interaction of RANTES with syndecan-1 and syndecan-4 expressed by human primary macrophages. Biochimica et Biophysica Acta 2003 1617 1-2 80 88 2-s2.0-0344154521 10.1016/j.bbamem.2003.09.006 (Pubitemid 37456715)
41. Fischereder M., Chemokines and chemokine receptors in renal transplantation-from bench to bedside. Acta Physiologica Hungarica 2007 94 1-2 67 81 2-s2.0-34248199301 10.1556/APhysiol.94.2007.1-2.7
42. + T cells. Science 1995 270 5243 1811 1815 2-s2.0-0029417004
43. + cells. European Journal of Immunology 1996 26 2 315 319 2-s2.0-0030065879 10.1002/eji.1830260207 (Pubitemid 26060235)